Stay updated on Baricitinib in Systemic Lupus Erythematosus Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Systemic Lupus Erythematosus Clinical Trial page.

Latest updates to the Baricitinib in Systemic Lupus Erythematosus Clinical Trial page
- CheckyesterdayChange DetectedFooter revision label updated from Revision: v3.3.3 to Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedFooter now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure link as well as Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed in the page history. This is a minor maintenance update that does not affect study information.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page history shows an internal version update (v3.3.1 added and v3.2.0 removed); the study records and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe government funding status notice was removed from the page.SummaryDifference0.3%

- Check73 days agoChange DetectedA new version entry was added to the record history, indicating an update to the study record. This change is limited to history tracking and does not modify core study content, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Baricitinib in Systemic Lupus Erythematosus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Systemic Lupus Erythematosus Clinical Trial page.